Send to

Choose Destination
See comment in PubMed Commons below
Expert Rev Vaccines. 2012 Jan;11(1):31-3. doi: 10.1586/erv.11.161.

First clinical trial of purified, irradiated malaria sporozoites in humans.

Author information

  • 1Swiss Tropical and Public Health Institute, Department of Medical Parasitology and Infection Biology, Socinstr. 57, CH 4002 Basel, Switzerland.


Purified, irradiated, metabolically active sporozoites of Plasmodium falciparum (PfSPZ) have been administered to 80 volunteers through subcutaneous or intradermal routes. This PfSPZ vaccine has been shown to be safe but of low immunogenicity and hence protective efficacy as shown after challenge with infected mosquitoes. Intravenous delivery of PfSPZ in nonhuman primates induced memory CD8(+) and CD4(+) T cells specific for PfSPZ that reside in the liver. Further studies using PfSPZ and the intravenous route in humans are warranted to fully explore the potential of purified, attenuated sporozoites for malaria vaccine development.


Publication Types

Publication Types

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center